Sign In

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.


METabolic EXplorer Prices IPO at €8.40 per Share and Raises Approximately €52 million
Successful IPO on Eurolist by Euronext Paris was oversubscribed 6 times

Not for distribution in the United States, Canada or Japan

Clermont-Ferrand, France, 10 April 2007 – METabolic EXplorer, an industrial biotechnology company focused on the bio-production of bulk chemicals (“Green Chemistry”), announced today that it has successfully completed its Initial Public Offering (IPO) of shares and its listing on Eurolist B by Euronext Paris.

Pursuant to the Offering, METabolic EXplorer will issue 6,181,041 new shares, including the fully exercised Extension Option, corresponding to gross proceeds of approximately €52 million. The final issue price amounts to €8.40 per share. METabolic EXplorer’s shares will commence trading on 11 April 2007 under the ticker symbol METEX. The payment of the shares and the completion of the capital increase are expected to take place on 12 April 2007.

The IPO attracted broad institutional demand from investors across Europe. The institutional part of the initial offering was 6 times oversubscribed, whereas the part reserved for retail investors was oversubscribed more than 3.5 times. The retail Offer in France (Open Price Offering) represented 10% of the offering (excluding the over-allotment option).

Credit Agricole Private Equity, a long standing shareholder of METabolic EXplorer, took advantage of the transaction to increase its shareholding in the company.

In connection with the offering, METabolic EXplorer has granted Fortis an option to subscribe for up to 927,156 newly issued shares at the offering price. This over-allotment option will be exercisable for a period of 30 days after the initial listing of METabolic EXplorer’s shares on the Eurolist by Euronext Paris.

Following the IPO, METabolic EXplorer will have 19,292,341 shares outstanding corresponding to a market capitalisation at the offering price of approximately €162 million, not including the shares for the over-allotment option. The offered shares represent 32% of the company's share capital, or 35% if the overallotment-option is exercised in full.

The Offering was organised by Fortis as Global Coordinator and Sole Bookrunner and CM-CIC Securities as Co-Lead Manager.

Benjamin Gonzalez, CEO of METabolic EXplorer, said: “The completion of our IPO is a major step in the company’s development. The funds raised will allow us to fulfil our ambition to transform the chemical value chain and gives us the means we need to become a world leader in green chemistry.”

“Our successful IPO clearly reflects the quality of the management team and all the people involved in this transaction,” he added.

Paul Michalet, CFO of METabolic EXplorer, commented: “We have been very encouraged by the positive response that we have received from the broad range of international investors that we have met as part of our IPO marketing process. We achieved strong support from high quality institutional investors across Europe, especially from those in France, Benelux, Germany and the UK. We look forward to operating as public company and executing our strategy which is designed to create significant value for all of our shareholders.”

- END-

About METabolic EXplorer

METabolic EXplorer is a leading industrial biotechnology company focused on the production of bulk chemicals (“Green Chemistry”). The company’s mission is to transform the chemical industry’s value chain by bringing to market more economically and environmentally attractive production processes.

METabolic EXplorer has developed a range of proprietary technologies which allow it to build highly efficient bacteria designed to produce existing bulk chemicals from a wide range of renewable feedstocks. This approach based on fermentation methods provide sustainable solutions to the chemical industry, offering significant economic benefits and are more environmental friendly than the current oil-dependent chemical processes.

METabolic EXplorer has developed cell factories for<

Publisher Contact Information:

METabolic EXplorer S.A.
+33 (0) 4 7333 4300

Company profile of METabolic EXplorer S.A.
Past press releases of METabolic EXplorer S.A..


Tech investments
From our Online Data Service
VC-backed companies
From our Radar

Recent Deals

Nov 25€24.0MInternet commerce
Nov 8N/AOther Computers & Electronics
Nov 5€2.1MAudio/Video
Nov 5€5.2MOther Computers & Electronics
Nov 5€0.4MInternet services
Nov 5€1.3MSecurity
Nov 5€1.5MAudio/Video

For information on Europe's most extensive database on technology funding click here!


Press Releases

Sep 30
tetavi raises $6 million to help more companies bring 3d holograms ...

May 28
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
nethone raised over $1 million from innovation nest

Mar 31
the fit allocates chf 100'000 to comppair technologies

Jan 29
yumpingo raises $10m to transform guest experiences in restaurants

About usContact usLegal Information
Copyright © 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.